|
PURE Pure Bioscience, Inc. Common Stock 1006028 |
| Balance Sheet |
|
Current Assets
|
$1,549,000.00 |
|
Assets
|
$1,558,000.00 |
|
Current Liabilities
|
$3,654,000.00 |
|
Liabilities
|
$7,397,000.00 |
|
Equity
|
$-5,839,000.00 |
|
Shares Out
|
130017569.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,324,000.00 |
|
Investing Cash Flow
|
$-33,000.00 |
| Market Analysis |
Market Cap
|
$9,101,229.83 |
|
Price
|
$0.06 |
|
PB
|
5.48 |
|
EPS
|
-0.01 |
|
PS
|
3.85 |
|
FCF
|
$-1,357,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:45 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:45 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PURE documents filed with the SEC.
PURE Filings
Clear
